Move Over, Apple: 16 More U.S. Companies Stashing Billions Overseas
Apple is under fire for keeping billions in profits overseas, where it doesn't have to pay U.S. taxes, but Apple is hardly the only big company dodging the IRS this way.
Apple is under fire for keeping billions in profits overseas, where it doesn't have to pay U.S. taxes, but Apple is hardly the only big company dodging the IRS this way.
J.C. Penney today opens its first store-within-the-store boutiques. They'll offer home goods from designers such as Michael Graves, Jonathan Adler and Sir Terence Conran.
Everyone knows Johnson & Johnson, but not everyone knows how big this pharmaceutical and medical device giant really is. And they also may not realize how much it's recent series of drug recalls and management missteps have pummeled the blue chip stock.
Birth control drugs that were heavily promoted as having fewer side effects are now under scrutiny from the FDA in the wake of new research suggesting that they are more likely to cause blood clots than older drugs.
Everybody knows how to make money in a bull market, and it isn't hard to see ways to profit from a bear market, but what do you do when the market isn't moving at all? Here are some strategies for making money in the doldrums.
Mergers and acquisitions are becoming ever more popular, with activity up 24% in the first two months of this year -- after already growing 23% in 2010. Here's how your portfolio can benefit from this trend.
The pharmaceutical industry is ready to fall off a cliff -- a "patent cliff." Over the next few years, some of the world's most popular and lucrative medicines will go off patent, and generic competition will siphon an estimated quarter of a trillion dollars from drugmakers' bottom lines.
"Do not not divide, crush, chew, or dissolve the tablet," reads the label on packages of Johnson & Johnson's Sudafed allergy and cold medicine. The company is recalling 667,632 packages for the typographical error.
Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting -- if not always positive -- year. Here's our rundown of the biggest health care stories.














